ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM)

NCT02194231 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

145

Enrollment

OTHER

Sponsor class

Conditions

Malignant Pleural Mesothelioma

Interventions

DRUG: Trabectedin

Sponsor

Mario Negri Institute for Pharmacological Research

Collaborators

[object Object]